Baystate Wealth Management’s Candel Therapeutics CADL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	$113K	Sell	76,910 -20,400	-21%	-$30K	0.01%	258
2023 Q3	$89.5K	Sell	97,310 -3,230	-3%	-$2.97K	0.01%	265
2023 Q2	$127K	Sell	100,540 -5,314	-5%	-$6.7K	0.01%	227
2023 Q1	$143K	Buy	+105,854	New	+$143K	0.01%	211